Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

477 results about "Cellular organisms" patented technology

Cellular organisms means the organisms which are formed of cells. They can be classified on the basis of number organisms That is all prokaryotes, algae etc.Those made of more then one cell is called multicellular. and the division of labour is found in different cells of the organism.For example generally eukaryotes like humans plants etc.

Compounds targeting blood vessels and their medical devices and their application in phototherapy for reducing redness

A compound, as shown in Formula I, is a multi-heterocyclic compound. It has been verified that the compound provided by this invention integrates a novel compound targeting the calcitonin gene-related peptide (CGRP) based on ephedrine. Upon contact with the skin, due to photoactivated cell biological function regulation and the blocking effect of the multi-heterocyclic compound I structure on serotonin receptors, it achieves therapeutic effects on cutaneous vascular malformations and telangiectasia, improves the effectiveness of phototherapy in improving chronic cutaneous vascular diseases, and promotes skin wound healing.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Transparent decellularized biological material as well as preparation method and application thereof

The invention relates to the technical field of biological materials, and particularly discloses a transparent acellular biological material as well as a preparation method and application thereof. The transparent decellularized biological material provided by the invention is prepared from animal membrane tissues, and the thickness of the transparent decellularized biological material is 1-500 microns; the light transmittance is 89.10% to 95.05%, the breaking strength is 6.21 N to 50.95 N, and the sewing strength is 2.24 N to 25.60 N. The biological material disclosed by the invention is high in transparency and good in strength, can be used in the field of repairing biological patch materials with relatively high requirements on transparency degree, and is wide in application prospect.
Owner:ABORIMEI (CHENGDU) MEDICAL TECH CO LTD

Immortalized cell of hepialus bat as well as construction method and application of immortalized cell

The invention belongs to the technical field of cell biology, and particularly relates to an immortalized cell of hepialus bat as well as a construction method and application of the immortalized cell. The monkey vacuolar virus 40T antigen gene or the human telomerase reverse transcriptase gene is overexpressed in a bat cell in a lentivirus infection mode; the bat cells comprise one or more of feneflower head bat lung cells, feneflower head bat kidney cells, meadowrue head bat lung cells and meadowrue head bat kidney cells; bat cells stably expressing monkey vacuolar virus 40T antigen or human telomerase reverse transcriptase are screened by using puromycin or magnaporthe oryzae, and the screened cells have the immortal characteristic while retaining the original karyotype of the bat cells, can be stably subcultured for more than 20 generations, and are vigorous in cell division, short in subculture time and irregular in shape.
Owner:INST OF PATHOGEN BIOLOGY CHINESE ACADEMY OF MEDICAL SCI

Recombinant fibronectin with enhanced function as well as preparation method and application thereof

The invention discloses a function-enhanced recombinant fibronectin as well as a preparation method and application thereof. The amino acid sequence of the recombinant fibronectin is shown as SEQ ID No.3, and the recombinant fibronectin is formed by fusing a main structural domain FN III8-10 formed by combining human fibronectin mutated into proline at the 171st site with integrin and a main structural domain FN III12-14 formed by combining the human fibronectin with cell factors. The recombinant fibronectin provided by the invention has enhanced cell proliferation and adhesion promoting performance of human fibroblasts, shows excellent cell biological efficacy, can be efficiently expressed in pichia pastoris engineering strains, and has wide application prospects in the fields of skin care, beauty and tissue engineering.
Owner:ZHEJIANG ZHUJI JUYUAN BIOTECHNOLOGY CO LTD

Exosome as well as preparation method and application thereof

The invention relates to the field of cell biology, and particularly discloses an exosome as well as a preparation method and application thereof. The method for preparing the exosome comprises the following steps: (1) introducing nucleotide sequences for coding a signal peptide TPA and an epidermal growth factor into an AAVS1 region of a host cell, such as a sequence shown in SEQ ID No.9 and a sequence shown in SEQ ID No.10, so as to obtain a modified host cell; and (2) collecting the exosome secreted by the modified host cell. The expression level of EGF mRNA in the exosome can be remarkably improved, so that the obtained exosome has a better effect in skin wound treatment.
Owner:NAT VACCINE & SERUM INST

SNP (Single Nucleotide Polymorphism) molecular marker related to age of pig in early estrus and application of SNP molecular marker

ActiveCN119020499APromotes ferroptosisDelay in the start of first loveMicrobiological testing/measurementArtificial cell constructsGranular cellPhysiology
The invention discloses an SNP (Single Nucleotide Polymorphism) molecular marker related to the age of a pig in the early estrus period and application of the SNP molecular marker. According to the invention, PLPP3 is taken as a research object, and molecular and cell biology methods are adopted to research the correlation between PLPP3 and the initial oestrus period: it is found that the promoter region g.155798586T > C and the promoter region g.155798718C > T are significantly related to the initial oestrus period (Plt; and further researches show that the TT genotype at the g.155798586 site and the CC genotype at the g.155798718 site promote the expression of the PLPP3, and confirm that the PLPP3 can promote ferroptosis of granulosa cells. Therefore, the mutation of the PLPP3 promoter region can influence the expression of the PLPP3, and the PLPP3 promotes the ferroptosis of the porcine ovarian granular cells, so that the initial estrus initiation is delayed. The method has good application value in research on ovarian follicle development, initial estrus initiation and the like.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Recycling media in suspended fluid bed reactor

The invention relates to a cell culture system (1) comprising: A bioreactor (100), comprising a vessel (110) and a recycling outlet (120), said recycling outlet (120) being positioned in the vessel (110) so as to be able to extract, from the vessel (110), a multiphase flow comprising a liquid phase and a gas phase; a separator (300) receiving the multiphase flow, said separator (300) being configured to accommodate and maintain a multiphasic system, comprising both the liquid phase and the gas phase; and a recycled media transfer line (220) adapted for routing of at least a portion of the liquid phase from the separator (300) to the bioreactor (100). The invention also relates to a cell culture method (1000) using a cell culture system (1) of the invention and cell biomass obtained thereof.
Owner:SUPRÊME

Neutralizing antibody GR12 for resisting novel coronavirus SARS-CoV-2 and variant and application of neutralizing antibody GR12

The invention discloses a novel coronavirus neutralizing antibody, a detection kit and application of the novel coronavirus neutralizing antibody. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR12 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR12 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR12 to S-Trimer and RBD under 2-fold and 300-fold dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR12 has high affinity and dilution stability and is suitable for clinical large-dose administration.
Owner:BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV +1

Product, system and method of cell cultivation

The present invention relates to a cell biomass (e.g. food product or pet food product) or its components prepared from cultivated metazoan cells, method of its preparation and a system for its preparation.
Owner:BTL HEALTHCARE TECH AS

Neutralizing antibody GR75 for resisting novel coronavirus SARS-CoV-2 and variant and application of neutralizing antibody GR75

The invention discloses a novel coronavirus neutralizing antibody, a detection kit and application of the novel coronavirus neutralizing antibody. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR75 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR75 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR75 to S-Trimer and RBD under 2-fold and 300-fold dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR75 has high affinity and dilution stability and is suitable for clinical large-dose administration.
Owner:BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV +1

Colorectal cancer large segmentation radiotherapy recurrence-resistant cell strain and application thereof

The invention discloses a recurrence-resistant cell strain for colorectal cancer large segmentation radiotherapy and application, and relates to the technical field of cell biology. The colorectal cancer large segmentation radiotherapy recurrence-resistant cell strain is preserved in the China Center for Type Culture Collection on January 2, 2025, the preservation address is Wuhan University, Wuhan, China, and the preservation number is CCTCC NO: C202533. By constructing the colorectal cancer large segmentation radiotherapy recurrence-resistant cell strain, a new biological material is provided for studying the radiotherapy recurrence-resistant colorectal cancer. The cell strain is screened in a mouse body with a sound immune system, has better physiological correlation, and is beneficial to research on the influence of an immune microenvironment on tumor cell radiotherapy resistance and the remodeling effect of radiotherapy resistant cells on the immune microenvironment. The cell strain can also monitor tumor recurrence after radiotherapy in real time through fluorescence imaging.
Owner:SHANDONG RES INST OF TUMOUR PREVENTION TREATMENT

Neutralizing antibody GR46 for resisting novel coronavirus SARS-CoV-2 and variant and application of neutralizing antibody GR46

The invention discloses a novel coronavirus neutralizing antibody GR46, a detection kit and application of the novel coronavirus neutralizing antibody GR46. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR46 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR46 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR46 to S-Trimer and RBD under 2-time and 300-time dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR46 has high affinity and dilution stability and is suitable for clinical large-dose administration.
Owner:BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV +1

Method for detecting cell stability

The invention belongs to the technical field of cell biology, and particularly relates to a method for detecting cell stability, a cell sample is detected in three aspects of cell performance, cell mutation and cell stability, and when the cell proliferation effect is good, the cell does not migrate, and the cell activity is gt; the cell of which the cell concentration is 80%, the cell early-stage and late-stage apoptosis ratio is less than or equal to 10%, the cell autophagy ratio is less than 5%, no proto-oncogene is remarkably expressed, the cell aging ratio is less than or equal to 20% and the cell multiplication time is less than 48 hours is a stable cell; if one of the indexes does not reach the standard, it is determined that cell passage is unstable, and the cell culture process is stopped. The method provided by the invention can comprehensively judge the life cycle of the cell, so that the cell is applied to the optimal economic / efficient service life, the cell state can be effectively and accurately judged, and the method has good reliability.
Owner:CHINA MEAT RES CENT

System for controllably inducing pyroptosis of tumor cells and application thereof

The invention discloses a system for controllably inducing pyroptosis of tumor cells and application of the system. The system comprises a red light activated Cre recombinase system and an expression vector of a GSDMDNT gene sequence of loxP flanking; the Cre recombinase system comprises: (1) an expression vector 1 containing a photosensitive protein PhyA gene sequence and a CreN59 sequence, and a connecting peptide located between the PhyA gene sequence and the CreN59 sequence; (2) an expression vector 2 containing a nucleoplasm shuttle protein FHY1 gene sequence and a CreC60 sequence, and a connecting peptide located between the FHY1 gene sequence and the CreC60 sequence; and (3) phycocyanobilin is contained. The system disclosed by the invention can be used for artificially and controllably regulating and controlling the expression of the cytotoxic gene GSDMDNT, so that directional and controllable pyroptosis induction is realized. The method can be applied to the fields of tumor therapy, gene therapy, cell biology and the like, and particularly has a wide application prospect in application scenarios requiring accurate control of gene expression.
Owner:SHENZHEN SECOND PEOPLES HOSPITAL (SHENZHEN INST OF TRANSLATIONAL MEDICINE) +1

Method for generating platelet-like particles based on MEG-01 cells and evaluating functions of platelet-like particles

The invention provides a method for generating platelet-like particles based on MEG-01 cells and evaluating functions of the platelet-like particles, and belongs to the technical field of cell biology. The invention provides a method for generating PLPs by inducing MEG-01 cells. According to the method, the MEG-01 cells are differentiated into PLPs with platelet characteristics by utilizing a PMA inducer. The PLPs disclosed by the invention has characteristic surface marker expression consistent with that of natural platelets, can respond to stimulation of an activator ADP, and shows biological functional characteristics of the platelets. The method for generating PLPs is simple and economical, experimental conditions are highly controllable, and an economical, efficient and repeatable in-vitro model is provided for functional research related to platelets.
Owner:RES CENT FOR ECO ENVIRONMENTAL SCI THE CHINESE ACAD OF SCI +1

System and method adapted for culturing animal cells at high-scale with low shear stress

The invention relates to a bioreactor (100) adapted for culturing animal cells, comprising: a vessel (110) defining a cultivation volume (111); at least two gas exchange devices (120) protruding in the vessel (110), each gas exchange devices (120) having a gaseous exchange surface (121) in the vessel (110); and at least one media inlet (130) and at least one media outlet (135), said media inlet (130) and outlet (135) being configured to operate simultaneously. The invention also relates to methods, cell biomass obtained from these methods and edible food products including this biomass.
Owner:SUPRÊME

Method for evaluating biological efficacy of NK (Natural Killer) cells by utilizing fluorescence detection and effect-target ratio

The invention discloses a method for evaluating biological efficacy of NK (Natural Killer) cells by utilizing fluorescence detection and an effect-target ratio. The method comprises the following steps: carrying out mixed culture on K562-Luc target cells and the NK cells; after the culture is finished, adding a fluorescein reaction substrate for incubation; after incubation is finished, the biological efficacy of the NK cells is evaluated by detecting a fluorescence detection value and combining an effect-target ratio. According to the method, a target cell strain line capable of stably expressing luciferase is constructed, and fluorescence change of target cells K562-Luc is recognized by combining a chemiluminescence detector of a microplate reader, so that the biological efficacy of the NK cells is simply and quickly detected with high sensitivity and high flux; and moreover, the required NK cell sample size is small, the operation is simple, and the evaluation cost is saved.
Owner:SHENZHEN FIRST CONDOR BIOSCIENCE CO LTD

MMP2 gene promoter region SNP (Single Nucleotide Polymorphism) site and application thereof in pig breeding

ActiveCN119410782Areduce cell viabilityInhibition of ferroptosisMicrobiological testing/measurementFood processingBiotechnologyGranular cell
The invention discloses an MMP2 gene promoter region SNP (Single Nucleotide Polymorphism) site and application thereof in pig breeding. According to the invention, an MMP2 gene promoter region is taken as a research object, and the relevance between the MMP2 gene promoter region and sow sexual maturity is researched by adopting a molecular and cell biology method, so that the situation that g.30088284G > A site and g.30088004C > T site are obviously related to the group maturity day age of Dumet black pigs is found; then different vectors are transfected, and different influences of different genotypes of the sites on the activity of the IRS1 gene promoter are studied. Further, sow ovarian granular cells are used as experimental materials, experimental technologies such as transcriptome sequencing, a total iron colorimetric method and a malondialdehyde colorimetric method are adopted, the influence of the MMP2 gene on the transcriptome level and ferroptosis of the sow ovarian granular cells is researched, and it is found that cell transcriptome differential genes influenced by the MMP2 gene are mainly enriched to signal channels such as cell differentiation; and ferroptosis of cells is promoted.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and / or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and / or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.
Owner:UNIVERSITY OF VIENNA +1

Nitrosyl peroxide response probe as well as preparation method and application thereof

The invention discloses a nitrosyl peroxide response probe as well as a preparation method and application thereof, and belongs to the technical field of biochemistry. The structural formula of the nitrosyl peroxide response probe is shown as a formula I, and R is hydrogen, a C1-C10 alkyl chain or an aromatic group. On the basis of replacing a rhodamine dye skeleton with phosphorus atoms, the ultrasensitive nitrosyl peroxide response probe is obtained through reasonable reduction reaction regulation and control design, destroy of a conjugated structure of molecules and formation of a non-conjugated precursor molecule with zero background fluorescence, and can be applied to nitrosyl peroxide imaging in cells and living bodies. And high-throughput screening of natural products with potential antioxidant activity is carried out.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Decellularized biomaterial from non-mammalian tissue

The growth factor profile, connective tissue matrix constituents, and immunoprivileged status of urodele extracellular matrix (ECM) and accompanying cutaneous tissue, plus the presence of antimicrobial peptides there, render urodele-derived tissue an ideal source for biological scaffolds for xenotransplantation. In particular, a biological scaffold biomaterial can be obtained by a process that entails (A) obtaining a tissue sample from a urodele, where the tissue comprises ECM, inclusive of the basement membrane, and (B) subjecting the tissue sample to a decellularization process that maintains the structural and functional integrity of the extracellular matrix, by virtue of retaining its fibrous and on-fibrous proteins, glycoaminoglycans (GAGs) and proteoglycans, while removing sufficient cellular components of the sample to reduce or eliminate antigenicity and immunogenicity for xenograft purposes. The resultant urodele-derived biomaterial can be used to enhance restoration of skin homeostasis, to reduce the severity, durations and associated damage caused by post-surgical inflammation, and to promote progression of natural healing and regeneration processes. In addition, the biomaterial promotes the formation of remodeled tissue that is comparable in quality, function, and compliance to undamaged human tissue.
Owner:NEXTGEN BIOLOGICS INC

Culture medium and culture method for fish primary liver cells

The invention belongs to the technical field of cell biology, and particularly discloses a culture medium and a culture method of fish primary liver cells. The culture medium of the fish primary liver cells comprises the following components: 90% of an M199 culture medium, 10% of fetal calf serum, 100 U / mL of penicillin, 0.1 mg / mL of streptomycin, 5 ng / mL of EGF, 10 [mu] U / ml of insulin and 10 mM of dexamethasone. Based on the culture medium, an efficient and stable fish liver cell culture method is developed by combining a standardized anesthesia and disinfection process, a precise dissection and liver sampling method, an optimized tissue digestion and cell separation scheme, an efficient cell purification and adherent culture system, a stable passage technology and the like; a standardized hepatocyte line establishment operation process is defined, and the problems that species binding exists in an existing fish liver cell culture method, and a standardized culture process suitable for multiple fish fingerlings is difficult to form are solved.
Owner:NINGBO UNIV

Preparation method of tumor enhanced targeting and therapeutic function extracellular vesicles and chip device

The invention belongs to the technical field of cell biology, and particularly relates to a preparation method of tumor enhanced targeting and therapeutic function extracellular vesicles and a chip device. The invention firstly provides an integrated chip device which is provided with a cell screening module and a functional preparation module and comprises a plurality of functional layers, wherein one functional layer is provided with a cell evolution screening area with gradient for cell screening, and the other functional layer is provided with a cell electric remodeling area for cell functionalization transformation. The invention innovatively proposes that tumor cells with strong metastasis ability are screened based on culture gradient, the tumor cells with stronger invasion ability are distinguished by utilizing spatial segmentation, then the screened cell subpopulation is transferred to a cell electric remodeling area in combination with overturning operation of the chip, and the cell subpopulation is transferred to the cell electric remodeling area in a manner of focusing an electric field through nanopores. And meanwhile, therapeutic molecules are efficiently delivered to realize cell transformation, so that the transformed cells can enhance the output of extracellular vesicles with a therapeutic function.
Owner:BEIHANG UNIV

Preparation method and application of recombinant human-like collagen

The invention discloses a preparation method and application of recombinant human-like collagen. The recombinant human-like collagen is fusion protein of collagen and elastin. The preparation method comprises the following steps: taking constructed escherichia coli engineering bacteria, inducing expression of human-like collagen through high-density fermentation, performing high-pressure homogeneous cell disruption after tubular centrifugal collection of fermented thalli, performing acid regulation, flocculating and settling of cell debris and host protein, and controlling pH and conductivity of feed liquid to obtain the human-like collagen. Through ion exchange chromatography purification and ultrafiltration concentration replacement, a human-like collagen stock solution with the liquid phase purity of more than 98% is obtained, and the total yield is more than 75%. Through cell biological activity detection and analysis, the purified human-like collagen has remarkable biological activity of promoting cell migration and adhesion. The whole preparation process developed by the invention is simple and convenient in process, high in yield, easy to amplify and suitable for industrial production of the recombinant human-like collagen, and the prepared protein raw material can be widely applied to the fields of medical beauty and biological medicine.
Owner:赣江中药创新中心

Application of BAG6 gene in regulation of influenza virus replication

The invention discloses an application of a BAG6 gene in regulation of influenza virus replication. The invention provides any one of the following applications of the substance for inhibiting expression of the BAG6 gene or the encoded protein thereof: 1) preparing a product for expanding propagation of influenza virus; 2) preparing a product for promoting influenza virus replication; and 3) preparing a product for improving the expression quantity of the influenza virus related protein. Experiments prove that the function of the BAG6 gene encoding protein is lost, and the BAG6 gene encoding protein can be used for researching the cell biological function of the BAG6 protein and the action and mechanism in other viruses; in addition, the strain has the potential of being applied to influenza vaccine production. Besides, overexpression is carried out on the BAG6 protein, it is found that the BAG6 protein can inhibit the replication titer of the influenza virus and the expression of the protein, and the effect of the BAG6 protein in influenza virus replication is explored from the two aspects of knockout and overexpression.
Owner:CHINA AGRI UNIV

Methods and products for transfecting cells

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.
Owner:FACTOR BIOSCIENCE INC

Novel ionizable lipid and lipid nanoparticle composition using same

The present invention relates to a novel ionizable lipid and a lipid nanoparticle composition using same. Lipid nanoparticles formed using the novel ionizable lipid exhibit an excellent gene encapsulation rate and intracellular / in vivo gene delivery rate, and exhibit excellent muscle delivery of genes through local injection, and thus can be effectively used as a composition for drug delivery.
Owner:MEDICIBIO CO LTD

Cell image segmentation and function prediction method and device and computer equipment

The invention discloses a cell image segmentation and function prediction method and device and computer equipment. The method comprises the steps of obtaining a to-be-processed cell image; inputting the to-be-processed cell image into the segmentation model for segmentation to obtain physical morphological features; inputting the physical morphological characteristics into a function prediction model to predict relevant parameters of the cell biological characteristics and relevant indexes of a set type of curative effect so as to obtain the parameters of the cell biological characteristics and the relevant indexes; and outputting physical morphological characteristics, cell biological characteristic parameters and related indexes. By implementing the method provided by the invention, the undyed bright field cell image can be effectively processed, the cell morphology and function are associated, the method is specially used for segmenting the mesenchymal stem cells, and the problem of instance segmentation under the condition of cell overlapping is solved.
Owner:CELLAUTO BIOLOGICAL AUTOMATION CO LTD

Application of FEN1 as target spot in treatment of cervical small cell neuroendocrine cancer

The invention belongs to the technical field of biomedicine, and particularly relates to application of FEN1 as a target spot in treatment of cervical small cell neuroendocrine cancer. In order to further explore molecular pathological reasons of the SCNECC and search for proper therapeutic targets or drugs, flap structure specific endonuclease 1 (FEN1) is used as a target gene for research, and the functions of FEN1 in the aspects of SCNECC cell proliferation, clone formation, migration, invasion, cell apoptosis and the like are verified through in-vitro and in-vivo experiments. And the molecular mechanism is preliminarily discussed by means of molecular biology. In addition, the influence of the inhibitor SC13 of FEN1 on cell biological behaviors such as SCNECC cell proliferation, clone formation, migration, invasion, cell apoptosis and the like is also verified. The result of the invention provides a new scientific basis for the molecular pathological reason of SCNECC, and provides a scientific evidence for FEN1 as a new therapeutic target.
Owner:SHANXI MEDICAL UNIV

Culture medium for inducing neural stem cells and application thereof

The invention relates to the technical field of cell biology, in particular to a culture medium for inducing neural stem cells and application thereof.The culture medium for inducing the neural stem cells comprises a neural ectoderm induction culture medium and a neural stem cell induction culture medium; the neural ectoderm induction culture medium is prepared from a basic culture medium, an N-2 additive, a B-27 additive, an inhibitor SB431542 and an inhibitor Dorsomorphin, the neural stem cell induction culture medium is prepared from a basic culture medium, an N-2 additive and a B-27 additive, the basic culture medium is composed of a DMEM / F12 culture medium, a Neurobase culture medium, GlutaMax and non-essential amino acid NEAA. The problems that neural stem cells obtained through an existing single-layer adherent induction method based on small molecules or growth factors are uneven in differentiation and low in purity are solved.
Owner:GUANGZHOU UBIGENE BIOSCIENCES CO LTD